Download PDF
Neuropediatrics 1993; 24(4): 232-234
DOI: 10.1055/s-2008-1071547
Short communication

© Georg Thieme Verlag KG Stuttgart · New York

Improvement of Myotonia with Carbamazepine in Three Cases with the Schwartz-Jampel Syndrome

H.  Topaloğlu , A.  Serdaroğlu , M.  Okan , K.  Gücüyener , M.  Topçu
  • Department of Pediatric Neurology, Hacettepe University Children's Hospital, Ankara, Turkey
Further Information

Publication History

Publication Date:
19 March 2008 (online)

Also available at
  PDF Download  Permissions and Reprints

Abstract

Carbamazepine was used as an anti-myotonic agent in three cases with the Schwartz-Jampel syndrome. Clinical myotonia, blepharospasm and a five-stair climbing test improved significantly within two to four months of the initiation of the medication. In the two cases which were followed three and two years, height shifted from under the 3rd centile to the 5th. Carbamezepine may be a drug of choice in the Schwartz-Jampel syndrome.

Key words

Schwartz-Jampel syndrome - Carbamazepine - Myotonia